Last ¥1,808 JPY
Change Today -17.00 / -0.93%
Volume 121.0K
4574 On Other Exchanges
As of 1:00 AM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

taiko pharmaceutical co ltd (4574) Snapshot

Previous Close
Day High
Day Low
52 Week High
12/1/14 - ¥2,545
52 Week Low
05/14/14 - ¥1,332
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TAIKO PHARMACEUTICAL CO LTD (4574)

Related News

No related news articles were found.

taiko pharmaceutical co ltd (4574) Related Businessweek News

No Related Businessweek News Found

taiko pharmaceutical co ltd (4574) Details

Taiko Pharmaceutical Co., Ltd. manufactures, procures, and sells non-prescription (OTC) drugs in Japan, Mainland China, Hong Kong, and Taiwan. It offers gastrointestinal drugs under the Seirogan, Seirogan TOI A, and Pishut brands for the treatment of loose stools, diarrhea, food poisoning, water poisoning, vomiting, and similar conditions; and designated quasi drugs comprising Trumpet Intestinal Regulator BF, as well as sells Hiya Kiogan, a prediatric drug. The company also manufactures and sells sanitation control products, such as Cleverin and WE'LL SHIELD; and sells LISPASS Cleverin generator, a machine which emits low concentrations of chlorine dioxide gas. In addition, it supplies products using the patented Cleverin technology through OEM agreements and products developed jointly with other companies. Further, the company provides additives and pyroligneous acids for horticultural use. Taiko Pharmaceutical Co., Ltd. was founded in 1946 and is headquartered in Osaka, Japan.

200 Employees
Last Reported Date: 06/26/14
Founded in 1946

taiko pharmaceutical co ltd (4574) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

taiko pharmaceutical co ltd (4574) Key Developments

Taiko Pharmaceutical Co., Ltd., Q2 2015 Earnings Call, Nov 19, 2014

Taiko Pharmaceutical Co., Ltd., Q2 2015 Earnings Call, Nov 19, 2014

Taiko Pharmaceutical Co., Ltd. to Report Q2, 2015 Results on Nov 12, 2014

Taiko Pharmaceutical Co., Ltd. announced that they will report Q2, 2015 results on Nov 12, 2014

Taiko Pharmaceutical Co., Ltd. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2014; provides earnings guidance for 2014

Taiko Pharmaceutical Co., Ltd. announced consolidated earnings results for the first quarter ended June 30, 2014. For the quarter, the company reported net sales of ¥1,453 million against ¥1,952 million a year ago. Operating income was ¥414 million against ¥622 million a year ago. Net income was $271 million or ¥20.75 per diluted share against ¥529 million ¥40.35 per diluted share a year ago. The company provided earnings guidance for 2014, the company forecast will be ¥8,200,000, operating income will be ¥1,560, net income will be ¥1,000,000 or ¥76.97 per share.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4574:JP ¥1,808.00 JPY -17.00

4574 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4574.
View Industry Companies

Industry Analysis


Industry Average

Valuation 4574 Industry Range
Price/Earnings 16.7x
Price/Sales 2.3x
Price/Book 1.9x
Price/Cash Flow 17.1x
TEV/Sales 1.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TAIKO PHARMACEUTICAL CO LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at